Viatris Kickstarts Business With Tentative Approval For Pediatric Dolutegravir
Company Claims To Be ‘The World’s Largest Supplier Of ARVs’
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
